TLR4 is a novel determinant of the response to paclitaxel in breast cancer. [electronic resource]
Producer: 20140401Description: 1676-87 p. digitalISSN:- 1538-8514
- Animals
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis Regulatory Proteins -- genetics
- Autocrine Communication
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Survival -- drug effects
- Disease Models, Animal
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression
- Humans
- Mice
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Paclitaxel -- pharmacology
- Phosphorylation
- Proto-Oncogene Proteins c-akt -- metabolism
- Receptors, Cytokine -- metabolism
- Toll-Like Receptor 4 -- genetics
- Transcriptional Activation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.